Hulud-like Sandworm_Mode supply chain attack targets NPM developers to steal secrets and poison AI assistants.
Iovance Biotherapeutics, Inc. demonstrates improved Q4 results, with $87M revenue and a 50% gross margin. Learn more about IOVA stock here.
Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsRichard Cathcart - Head of Investor RelationsMartin de ...
A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results